Sherwin CM - Search Results

1

Fundamentals of population pharmacokinetic modelling: validation methods.

Sherwin CM, Kiang TK, Spigarelli MG, Ensom MH. Sherwin CM, et al. Clin Pharmacokinet. 2012 Sep 1;51(9):573-90. doi: 10.1007/BF03261932. Clin Pharmacokinet. 2012. PMID: 22799590 Review.

2

The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune disease.

Sherwin CM, Fukuda T, Brunner HI, Goebel J, Vinks AA. Sherwin CM, et al. Clin Pharmacokinet. 2011 Jan;50(1):1-24. doi: 10.2165/11536640-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21142265 Free PMC article. Review.

3

Optimal study design for pioglitazone in septic pediatric patients.

Sherwin CM, Ding L, Kaplan J, Spigarelli MG, Vinks AA. Sherwin CM, et al. J Pharmacokinet Pharmacodyn. 2011 Aug;38(4):433-47. doi: 10.1007/s10928-011-9202-8. Epub 2011 Jun 11. J Pharmacokinet Pharmacodyn. 2011. PMID: 21667139 Free PMC article.

4

Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.

Zobell JT, Stockmann C, Young DC, Cash J, McDowell BJ, Korgenski K, Sherwin CM, Spigarelli M, Chatfield BA, Ampofo K. Zobell JT, et al. Among authors: sherwin cm. Clin Ther. 2011 Nov;33(11):1844-50. doi: 10.1016/j.clinthera.2011.09.010. Epub 2011 Oct 21. Clin Ther. 2011. PMID: 22018680

5

Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance.

De Cock RF, Allegaert K, Schreuder MF, Sherwin CM, de Hoog M, van den Anker JN, Danhof M, Knibbe CA. De Cock RF, et al. Among authors: sherwin cm. Clin Pharmacokinet. 2012 Feb 1;51(2):105-17. doi: 10.2165/11595640-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22229883

6

Fundamentals of population pharmacokinetic modelling: modelling and software.

Kiang TK, Sherwin CM, Spigarelli MG, Ensom MH. Kiang TK, et al. Among authors: sherwin cm. Clin Pharmacokinet. 2012 Aug 1;51(8):515-25. doi: 10.2165/11634080-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22676301 Review.

7

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems.

Zobell JT, Young DC, Waters CD, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG. Zobell JT, et al. Among authors: sherwin cm. Pediatr Pulmonol. 2012 Dec;47(12):1147-58. doi: 10.1002/ppul.22655. Epub 2012 Aug 21. Pediatr Pulmonol. 2012. PMID: 22911974 Review.

8

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.

Young DC, Zobell JT, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG. Young DC, et al. Among authors: sherwin cm. Pediatr Pulmonol. 2013 Jan;48(1):1-7. doi: 10.1002/ppul.22664. Epub 2012 Sep 4. Pediatr Pulmonol. 2013. PMID: 22949160

9

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.

Stockmann C, Sherwin CM, Zobell JT, Young DC, Waters CD, Spigarelli MG, Ampofo K. Stockmann C, et al. Among authors: sherwin cm. Pediatr Pulmonol. 2013 Mar;48(3):211-20. doi: 10.1002/ppul.22667. Epub 2012 Sep 4. Pediatr Pulmonol. 2013. PMID: 22949224 Review.

10

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.

Zobell JT, Waters CD, Young DC, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG. Zobell JT, et al. Among authors: sherwin cm. Pediatr Pulmonol. 2013 Feb;48(2):107-22. doi: 10.1002/ppul.22669. Epub 2012 Sep 4. Pediatr Pulmonol. 2013. PMID: 22949297 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters